SANN HOLGER
No ORCID on file
· 48 papers in corpus
· active 2005-2006
2006
The present invention relates to a novel medicinal use of 5-HT3 receptor antagonists, in particular cilansetron, or their pharmacologically compatible derivatives like salts and/or solvates, for the treatment and/or prophylaxis of non-diges…
2006
The present invention relates to a novel medicinal use of 5-HT3 receptor antagonists, in particular cilansetron, or their pharmacologically compatible derivatives like salts and/or solvates, for the treatment and/or prophylaxis of non-diges…
2006
The present invention relates to a novel medicinal use of 5-HT3 receptor antagonists, in particular cilansetron, or their pharmacologically compatible derivatives like salts and/or solvates, for the treatment and/or prophylaxis of non-diges…
2006
The present invention relates to a novel medicinal use of 5-HT3 receptor antagonists, in particular cilansetron, or their pharmacologically compatible derivatives like salts and/or solvates, for the treatment and/or prophylaxis of non-diges…
2006
The present invention relates to a novel medicinal use of 5-HT3 receptor antagonists, in particular cilansetron, or their pharmacologically compatible derivatives like salts and/or solvates, for the treatment and/or prophylaxis of non-diges…
2006
The present invention relates to a novel medicinal use of 5-HT3 receptor antagonists, in particular cilansetron, or their pharmacologically compatible derivatives like salts and/or solvates, for the treatment and/or prophylaxis of non-diges…
2006
The present invention relates to a novel medicinal use of 5-HT3 receptor antagonists, in particular cilansetron, or their pharmacologically compatible derivatives like salts and/or solvates, for the treatment and/or prophylaxis of non-diges…
2006
The present invention relates to a novel medicinal use of 5-HT3 receptor antagonists, in particular cilansetron, or their pharmacologically compatible derivatives like salts and/or solvates, for the treatment and/or prophylaxis of non-diges…
2006
The present invention relates to a novel medicinal use of 5-HT3 receptor antagonists, in particular cilansetron, or their pharmacologically compatible derivatives like salts and/or solvates, for the treatment and/or prophylaxis of non-diges…
2006
The present invention relates to a novel medicinal use of 5-HT3 receptor antagonists, in particular cilansetron, or their pharmacologically compatible derivatives like salts and/or solvates, for the treatment and/or prophylaxis of non-diges…
2006
The present invention relates to a novel medicinal use of 5-HT3 receptor antagonists, in particular cilansetron, or their pharmacologically compatible derivatives like salts and/or solvates, for the treatment and/or prophylaxis of non-diges…
2006
The present invention relates to a novel medicinal use of 5-HT3 receptor antagonists, in particular cilansetron, or their pharmacologically compatible derivatives like salts and/or solvates, for the treatment and/or prophylaxis of non-diges…
2006
The present invention relates to a novel medicinal use of 5-HT3 receptor antagonists, in particular cilansetron, or their pharmacologically compatible derivatives like salts and/or solvates, for the treatment and/or prophylaxis of non-diges…
2006
The present invention relates to a novel medicinal use of 5-HT3 receptor antagonists, in particular cilansetron, or their pharmacologically compatible derivatives like salts and/or solvates, for the treatment and/or prophylaxis of non-diges…
2006
The present invention relates to a novel medicinal use of 5-HT3 receptor antagonists, in particular cilansetron, or their pharmacologically compatible derivatives like salts and/or solvates, for the treatment and/or prophylaxis of non-diges…
2006
The present invention relates to a novel medicinal use of 5-HT3 receptor antagonists, in particular cilansetron, or their pharmacologically compatible derivatives like salts and/or solvates, for the treatment and/or prophylaxis of non-diges…
2005
The present invention relates to a novel medicinal use of 5-HT3 receptor antagonists, in particular cilansetron, or their pharmacologically compatibl e derivatives like salts and/or solvates, for the treatment and/or prophylaxis of non-dige…
2005
The present invention relates to a novel medicinal use of 5-HT3 receptor antagonists, in particular cilansetron, or their pharmacologically compatibl e derivatives like salts and/or solvates, for the treatment and/or prophylaxis of non-dige…
2005
The present invention relates to a novel medicinal use of 5-HT3 receptor antagonists, in particular cilansetron, or their pharmacologically compatibl e derivatives like salts and/or solvates, for the treatment and/or prophylaxis of non-dige…
2005
The present invention relates to a novel medicinal use of 5-HT3 receptor antagonists, in particular cilansetron, or their pharmacologically compatibl e derivatives like salts and/or solvates, for the treatment and/or prophylaxis of non-dige…
2005
The present invention relates to a novel medicinal use of 5-HT3 receptor antagonists, in particular cilansetron, or their pharmacologically compatible derivatives like salts and/or solvates, for the treatment and/or prophylaxis of non-diges…
2005
The present invention relates to a novel medicinal use of 5-HT3 receptor antagonists, in particular cilansetron, or their pharmacologically compatibl e derivatives like salts and/or solvates, for the treatment and/or prophylaxis of non-dige…
2005
The present invention relates to a novel medicinal use of 5-HT3 receptor antagonists, in particular cilansetron, or their pharmacologically compatibl e derivatives like salts and/or solvates, for the treatment and/or prophylaxis of non-dige…
2005
The present invention relates to a novel medicinal use of 5-HT3 receptor antagonists, in particular cilansetron, or their pharmacologically compatible derivatives like salts and/or solvates, for the treatment and/or prophylaxis of non-diges…
2005
The present invention relates to a novel medicinal use of 5-HT3 receptor antagonists, in particular cilansetron, or their pharmacologically compatible derivatives like salts and/or solvates, for the treatment and/or prophylaxis of non-diges…